Latest Diabetes Research

IDegLira improves long-term health outcomes and reduces costs for diabetes patients

This study analyzed the long-term cost-effectiveness of IDegLira for treating type 2 diabetes in China, showing significant improvements in glycemic control and health outcomes.

PES treatment improves glucose control in type 2 diabetes patients

This study investigated the impact of peripheral electrical stimulation on glucose control in type 2 diabetes patients, showing significant improvements in nocturnal glucose control.

Lifestyle changes may improve diabetes remission rates

This study evaluated the effects of a one-year lifestyle intervention on type 2 diabetes patients who achieved remission, finding significant improvements in various metabolic parameters.

Mediterranean diet may improve insulin response in type 2 diabetes

This study evaluated the postprandial effects of three diets in patients with type 2 diabetes, finding significant differences in insulin and glucose responses.

Boscia senegalensis extract (BSP), a natural SGLT1/2 inhibitor, may lower blood sugar and HbA1c in type 2 diabetes

Empagliflozin reduces mortality in real-world type 2 diabetes patients, including those excluded from pivotal trials

Exercise improved balance and cognition in adults with type 2 diabetes

Remote nutrition education with low-carb diet improves blood sugar and reduces medication use in type 2 diabetes

Empagliflozin may improve nighttime blood sugar patterns in type 1 diabetes

Metformin and glimepiride with basal insulin lowered HbA1c the most